With Genetic Test Codes Developed, CMS Undecided On How To Pay For Them
This article was originally published in The Pink Sheet Daily
Specific reimbursement codes have been developed for the first time for more than 100 genetic tests, but they will not be adopted by Medicare until at least 2013 as CMS figures out how to incorporate them into the payment system..
You may also be interested in...
California Medicare administrator Palmetto GBA is implementing tougher provider claims rules to more closely manage payment for new genetic tests
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.